Sam Smith on the Association Between Adherence and Menopausal Symptoms

Video

Sam Smith, PhD, discusses the relationship between menopausal symptoms and non-adherence in patients receiving tamoxifen.

Sam Smith, PhD, from University of Leeds, discusses the association between menopausal symptoms and adherence for patients with breast cancer taking tamoxifen.

This trial matched a patient’s adherence to the menopausal symptoms they experienced. Symptoms measured were headaches, nausea and vomiting, gynecologic issues, and hot flashes. Although no association was found between gynecologic symptoms or hot flashes and nonadherence, researchers did find that patients who experienced nausea and vomiting or headaches were less likely to adhere to their medication.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with dark curly hair wearing a floral shirt
3 experts in this video
3 experts in this video
Image of a woman with gray hair on a light blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a private infusion bay with a large screen for video calls
2 experts are featured in this series.
Related Content
Amanda Brink discusses AI-driven image analysis in HER2 scoring in breast cancer.

Opinion: Artificial Intelligence Enhances Precision in HER2 Scoring for Breast Cancer

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
May 19th 2025
Article

Oncology nurses can help advocate for AI-assisted diagnostic improvements.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Graphic of a breast with a tumor

T-DXd Regimen Improves pCR in Early HER2+ Breast Cancer

Sabrina Serani
May 13th 2025
Article

T-DXd followed by THP improved pCR in high-risk, early-stage HER2+ breast cancer in the phase 3 DESTINY-Breast11 trial.

The Vitals

Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

Lindsay Fischer
January 16th 2023
Podcast

Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.

Photo of acupuncture needles resting in a bowl

Acupuncture Use in BC Predicted by Social Determinants of Health

Ariana Pelosci
April 22nd 2025
Article
Anatomical image of a breast with a tumor

Q&A: Prioritizing QOL Important to Treating HR+, HER2- Metastatic Breast Cancer

John Novak, PA-C
Published: April 17th 2025 | Updated: May 5th 2025
Article

When treating patients with hormone-receptor positive, HER2-negative metastatic breast cancer, mutations necessitate the prioritization of quality of life.